New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer
The ONCPI emerges as a significant prognostic marker for predicting NACT outcome in advanced HGSOC patients and holds promise for integration into clinical practice and risk-stratified trial design.
Authors
- Jingxiang Wu (ORCID: https://orcid.org/0000-0002-2858-9668)
- Shaolin Ma (ORCID: https://orcid.org/0000-0002-3368-8054)
- Chunxian Huang (ORCID: https://orcid.org/0000-0001-6022-598X)
- Yuhao Zhang (ORCID: https://orcid.org/0000-0002-6801-9010)
- Dongdong Ye (ORCID: https://orcid.org/0000-0002-3377-0656)
- Aoshuang Cheng (ORCID: https://orcid.org/0000-0003-1353-0185)
- Miaochun Xu (ORCID: https://orcid.org/0000-0002-9023-1755)
- Chuying Huo (ORCID: https://orcid.org/0000-0003-3513-4271)
- Huaiwu Lu (ORCID: https://orcid.org/0000-0002-7668-3333)
- Bowen Li (ORCID: https://orcid.org/0000-0002-7166-2672)
- Zhongqiu Lin
- Yunyun Liu (ORCID: https://orcid.org/0000-0001-8437-6803)
Institutions
- Union Hospital (HK)
- Sun Yat-sen University (CN)
- Guangdong Province Stomatological Hospital (CN)
- Sun Yat-sen Memorial Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1186/s12885-024-13324-0
- Citations
- 2
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- Beijing Xisike Clinical Oncology Research Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province